Candorium Free Members
Join Candorium to access the full article and more
Free Member Benefits:
✔
Comment & Reply✔
Newsletter Access✔
Follow Authors✔
Share via SMS Go Back
Aridis Pharmaceuticals, Inc. reports $6.8 million Q1 profit
By USInMinutes - Jun 09, 2023, 08:26 AM ET
Last Updated - Jul 18, 2023, 03:12 PM EDT
The company generated $1.10 million in quarterly revenue
Aridis Pharmaceuticals, Inc. [ARDS] has reported fiscal Q1 profit of $6.80 million.
On a per-share basis, the DE based company said its diluted earnings are $0.22.
The Pharmaceutical Preparations firm posted revenue of $1.10 million in this period.
Also Read:
- Aridis Pharmaceuticals Announces First Quarter 2023 Financial Results and Business Update
- Aridis Receives Agreement from the FDA on a Single Confirmatory Phase 3 Study of AR-301 and the ...
- Aridis Pharmaceuticals Receives Nasdaq Notice on Late Filing of its Form 10-Q
- Aridis Pharmaceuticals Receives Nasdaq Notice on Late Filing of its Form 10-K
- Aridis Provides Corporate Update
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Sponsored
Read More from Investing
Popular News
Latest News